OVARIAN-CANCER AND LONG-TERM TAMOXIFEN IN PREMENOPAUSAL WOMEN

被引:23
作者
SPICER, DV
PIKE, MC
HENDERSON, BE
机构
关键词
D O I
10.1016/0140-6736(91)93096-R
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1414 / 1414
页数:1
相关论文
共 6 条
[1]   EFFECT OF ANTI-OESTROGEN TAMOXIFEN ON PLASMA-LEVELS OF LUTEINIZING-HORMONE, FOLLICLE-STIMULATING-HORMONE, PROLACTIN, ESTRADIOL AND PROGESTERONE IN NORMAL PREMENOPAUSAL WOMEN [J].
GROOM, GV ;
GRIFFITHS, K .
JOURNAL OF ENDOCRINOLOGY, 1976, 70 (03) :421-428
[2]  
HENDERSON BE, 1982, CANCER RES, V42, P3232
[3]  
MANNI A, 1980, CANCER TREAT REP, V64, P779
[4]  
MESSINIS IE, 1982, ACTA OBSTET GYN SCAN, V61, P377
[5]   A PILOT TRIAL TO EVALUATE THE ACUTE TOXICITY AND FEASIBILITY OF TAMOXIFEN FOR PREVENTION OF BREAST-CANCER [J].
POWLES, TJ ;
HARDY, JR ;
ASHLEY, SE ;
FARRINGTON, GM ;
COSGROVE, D ;
DAVEY, JB ;
DOWSETT, M ;
MCKINNA, JA ;
NASH, AG ;
SINNETT, HD ;
TILLYER, CR ;
TRELEAVEN, JG .
BRITISH JOURNAL OF CANCER, 1989, 60 (01) :126-131
[6]   ENDOCRINE CONSEQUENCES OF CONTINUOUS ANTI-ESTROGEN THERAPY WITH TAMOXIFEN IN PREMENOPAUSAL WOMEN [J].
SHERMAN, BM ;
CHAPLER, FK ;
CRICKARD, K ;
WYCOFF, D .
JOURNAL OF CLINICAL INVESTIGATION, 1979, 64 (02) :398-404